• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Materialise NV

    4/22/25 11:02:34 AM ET
    $MTLS
    Computer Software: Prepackaged Software
    Technology
    Get the next $MTLS alert in real time by email
    S-8 1 tm251054d2_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on April 22, 2025

     

    Registration Statement No. 333-

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM S-8
    REGISTRATION STATEMENT

    UNDER
    THE SECURITIES ACT OF 1933

     

    MATERIALISE NV
    (Exact name of registrant as specified in its charter)

     

    Kingdom of Belgium Not Applicable

    (State or other jurisdiction of

    incorporation or organization)

    (I.R.S. employer

    identification no.)

     

    Technologielaan 15
    3001 Leuven
    Belgium
    (Address of principal executive offices)

     

    Warrants Plan 2023
    (Full title of the Plan)

     

    Materialise USA, LLC
    44650 Helm Ct.
    Plymouth, Michigan 48170
    Attention: Chief Executive Officer
    (734) 259-6445
    (Name, address and telephone number of agent for service)

     

    Copies to:

     

    Per B. Chilstrom, Esq. 

    Fenwick & West LLP 

    902 Broadway 

    New York, New York 10010 

    (212) 430-2600

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

     

    Large accelerated filer ¨ Accelerated filer x
           
    Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company ¨

     

     

     

     

     

    PART I
    INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS

     

    Item 1.Plan Information.

     

    Item 2.Registrant Information and Employee Plan Annual Information.*

     

    *In accordance with Rule 428(b) under the Securities Act, the documents containing the information called for by Part I of Form S-8 will be sent or given to individuals who participate in the Warrants Plan 2023 and are not being filed with or included in this Form S-8. These documents and the documents incorporated by reference in this registration statement pursuant to Item 3 of Part II of Form S-8, taken together, constitute the prospectus that meets the requirements of Section 10(a) of the Securities Act.

     

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3.Incorporation of Documents by Reference.

     

    The following documents, which have been filed by the registrant with the Securities and Exchange Commission (the “Commission”) are hereby incorporated by reference herein, and shall be deemed to be a part of, this registration statement:

     

    ·Annual Report on Form 20-F for the year ended December 31, 2024 filed with the Commission on April 22, 2025; and

     

    ·The description of the ordinary shares and American depositary shares (“ADSs”) contained in the registration statement on Form 8-A (File No. 001-36515), filed with the Commission on June 20, 2014 pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as updated by the description of the ordinary shares and ADSs contained in Exhibit 2.3 to the Annual Report on Form 20-F for the year ended December 31, 2020, filed with the Commission on April 30, 2021, and any subsequent amendments or reports filed for the purpose of updating such description.

     

    In addition, all documents filed by the registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this registration statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part of it from the respective dates of filing such documents; except as to any portion of any future annual, quarterly or current report or other document that is deemed furnished and not deemed filed under such provisions. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

     

    Item 4.Description of Securities.

     

    Not applicable

     

    Item 5.Interests of Named Experts and Counsel.

     

    Not applicable

     

    Item 6.Indemnification of Directors and Officers.

     

    Under Belgian law, the directors of a company may be liable for damages to the company in case of improper performance of their duties. The registrant’s directors may be liable to the registrant and to third parties for infringement of the registrant’s articles of association or Belgian company law. Under certain circumstances, directors may be criminally liable. The registrant maintains liability insurance for the benefit of its directors and senior management.

     

     

     

    In order to provide enhanced liability protection for its directors and to attract and retain highly qualified individuals to act as directors, in connection with this offering, the registrant’s board of directors intends to approve the undertaking to indemnify each current and future member of the board of directors to the maximum extent permitted by law, except if the liability or expense is covered by insurance taken by the registrant or if the liability of a director would arise out of such director’s fraud or willful misconduct.

     

    In the underwriting agreement related to the initial public offering, the underwriters have agreed to indemnify, under certain conditions, the registrant, its directors and officers and persons who control the registrant within the meaning of the Securities Act, against certain liabilities.

     

    Item 7.Exemption from Registration Claimed.

     

    Not applicable

     

    Item 8.Exhibits.

     

    Exhibit
    number
      Exhibit description
         
    4.1   Restated Articles of Association of Materialise NV (English translation) (incorporated by reference to Exhibit 1.1 to the annual report on Form 20-F for the year ended December 31, 2022)
         
    4.2   Form of Deposit Agreement (incorporated by reference to Exhibit 4.1 to the registration statement on Form F-1 (File No. 333-194982))
         
    4.3   Warrant Plan 2023 (English translation) (incorporated by reference to Exhibit 4.5 to the annual report on Form 20-F for the year ended December 31, 2023)
         
    4.4   Form of Warrant Agreement under Warrant Plan 2023 (English translation) (incorporated by reference to Exhibit 4.3 to the annual report on Form 20-F for the year ended December 31, 2024)
         
    5.1*   Opinion of Intui CV
         
    23.1*   Consent of KPMG Bedrijfsrevisoren BV / KPMG Réviseurs d’Entreprises SRL, independent registered public accounting firm
         
    23.2*   Consent of Intui CV (contained in Exhibit 5.1)
         
    24.1*   Power of Attorney (included in signature page)
         
    107.1*   Filing Fee Table

     

    * Filed herewith.

     

    Item 9.Undertakings.

     

    (a)The undersigned registrant hereby undertakes:

     

    (1)To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

    (i)To include any prospectus required by section 10(a)(3) of the Securities Act;

     

    (ii)To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

     

    2

     

     

    (iii)To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

     

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.

     

    (2)That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    (b)The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Exchange Act), that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (c)Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    3

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in Leuven, Belgium on April 22, 2025.

     

      Materialise NV
       
      By: /s/ Brigitte de Vet-Veithen 
      Name: Brigitte de Vet-Veithen 
        De Vet Management BV
       
      Title: Chief Executive Officer

     

    4

     

     

    POWER OF ATTORNEY

     

    Each person whose signature appears below hereby constitutes and appoints Brigitte de Vet and Koen Berges and each of them, as his attorney-in-fact and agent, with full power of substitution and resubstitution for him in any and all capacities, to sign any or all amendments or post-effective amendments to this registration statement, or any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto such attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifying and confirming all that such attorney-in-fact and agent or his substitutes may do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name   Title   Date
         
    /s/ Brigitte de Vet-Veithen   Chief Executive Officer and Director (Principal   April 19, 2025

    De Vet Management, represented by

    Brigitte de Vet-Veithen

      Executive Officer)    
         
    /s/ Koen Berges   Chief Financial Officer (Principal Financial Officer   April 20, 2025
    Finstraco, represented by Koen Berges   and Principal Accounting Officer)    
         
    /s/ Wilfried Vancraen   Chairman of the Board   April 22, 2025
    Wilfried Vancraen        
         
    /s/ Peter Leys   Director   April 22, 2025
    Peter Leys        
         
    /s/ Johan De Lille   Director   April 18, 2025
    A Tre C CVOA, represented by        
    Johan De Lille        
         
    /s/ Hilde Ingelaere   Director    April 22, 2025
    Hilde Ingelaere        
         
    /s/ Sander Vancraen   Director   April 22, 2025
    Sander Vancraen        
         
    /s/ Jürgen Ingels   Director   April 17, 2025
    Jürgen Ingels        
         
    /s/ Jos Vander Sloten   Director   April 17, 2025
    Jos Vander Sloten        
         
    /s/ Lieve Verplancke   Director    April 20, 2025
    Lieve Verplancke        
         
    /s/ Bart Luyten   Director   April 17, 2025
    Bart Luyten        
         
    /s/ Volker Hammes   Director   April 19, 2025
    Volker Hammes        
             
    /s/ Bryan L. Crutchfield   Authorized Representative in the United States   April 22, 2025
    Bryan L. Crutchfield        

     

    5

     

    Get the next $MTLS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MTLS

    DatePrice TargetRatingAnalyst
    4/24/2024$9.50Overweight
    Cantor Fitzgerald
    5/26/2023$11.00Hold → Buy
    Kepler
    3/25/2022$20.00Buy → Neutral
    Bryan Garnier
    10/20/2021$28.00Overweight
    JP Morgan
    9/2/2021$30.00Buy
    Stifel
    8/9/2021$30.00Buy
    Lake Street
    More analyst ratings

    $MTLS
    Financials

    Live finance-specific insights

    See more
    • Materialise Reports First Quarter 2025 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2025. Highlights – First Quarter 2025 Boosted by 18.7% growth in our Materialise Medical segment, total revenue increased by 4.3% to 66,379 kEUR for the first quarter of 2025 compared to the corresponding 2024 period. Total deferred revenues from software maintenance and license fees increased during the quarter by 1,921 kEUR, to 48,870 kEUR. Adjusted EBIT improved to 646 kEUR for the first quarter of 2025 from (1,195) kEUR for the fourth quarter of 2024, but remained belo

      4/24/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the first quarter ended March 31, 2025 on Thursday, April 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the first quarter 2025 financial results on Thursday, April 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference call:

      4/14/25 10:12:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise Reports Fourth Quarter and Full Year 2024 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Highlights – Fourth Quarter 2024 Total revenue increased 0.6% to 65,680 kEUR for the fourth quarter of 2024 from 65,295 kEUR for the corresponding 2023 period boosted by 14.3% growth in our Materialise Medical segment. Total deferred revenues from software maintenance and license fees increased by 5,878 kEUR this quarter to 46,948 kEUR. Adjusted EBITDA amounted to 4,306 kEUR for the fourth quarter of 2024 compared to 8,474 kEUR for the cor

      2/20/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    SEC Filings

    See more
    • SEC Form SD filed by Materialise NV

      SD - MATERIALISE NV (0001091223) (Filer)

      5/13/25 9:21:16 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Materialise NV

      6-K - MATERIALISE NV (0001091223) (Filer)

      4/24/25 7:45:29 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Materialise NV

      6-K - MATERIALISE NV (0001091223) (Filer)

      4/24/25 7:44:01 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Materialise NV (Amendment)

      SC 13G/A - MATERIALISE NV (0001091223) (Subject)

      2/10/23 1:44:50 PM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Materialise NV (Amendment)

      SC 13G/A - MATERIALISE NV (0001091223) (Subject)

      2/14/22 6:05:34 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Materialise NV (Amendment)

      SC 13G/A - MATERIALISE NV (0001091223) (Subject)

      2/9/22 2:44:00 PM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald initiated coverage on Materialise with a new price target

      Cantor Fitzgerald initiated coverage of Materialise with a rating of Overweight and set a new price target of $9.50

      4/24/24 6:23:39 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise upgraded by Kepler with a new price target

      Kepler upgraded Materialise from Hold to Buy and set a new price target of $11.00

      5/26/23 7:40:13 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise downgraded by Bryan Garnier with a new price target

      Bryan Garnier downgraded Materialise from Buy to Neutral and set a new price target of $20.00

      3/25/22 9:23:58 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Materialise Reports First Quarter 2025 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2025. Highlights – First Quarter 2025 Boosted by 18.7% growth in our Materialise Medical segment, total revenue increased by 4.3% to 66,379 kEUR for the first quarter of 2025 compared to the corresponding 2024 period. Total deferred revenues from software maintenance and license fees increased during the quarter by 1,921 kEUR, to 48,870 kEUR. Adjusted EBIT improved to 646 kEUR for the first quarter of 2025 from (1,195) kEUR for the fourth quarter of 2024, but remained belo

      4/24/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the first quarter ended March 31, 2025 on Thursday, April 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the first quarter 2025 financial results on Thursday, April 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference call:

      4/14/25 10:12:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise Reports Fourth Quarter and Full Year 2024 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Highlights – Fourth Quarter 2024 Total revenue increased 0.6% to 65,680 kEUR for the fourth quarter of 2024 from 65,295 kEUR for the corresponding 2023 period boosted by 14.3% growth in our Materialise Medical segment. Total deferred revenues from software maintenance and license fees increased by 5,878 kEUR this quarter to 46,948 kEUR. Adjusted EBITDA amounted to 4,306 kEUR for the fourth quarter of 2024 compared to 8,474 kEUR for the cor

      2/20/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Leadership Updates

    Live Leadership Updates

    See more
    • 3D Printing Pioneer Materialise Appoints Brigitte de Vet-Veithen as New CEO

      Fried Vancraen, Co-founder and CEO, to become Chairman of the Board Materialise NV (NASDAQ:MTLS), a global leader in 3D printing software and services, today announced that the company's Board of Directors has appointed Brigitte de Vet-Veithen as Chief Executive Officer. Brigitte de Vet-Veithen will succeed Fried Vancraen, who co-founded Materialise in 1990 and has served as the company's CEO for 33 years. Mr. Vancraen will continue to represent Materialise as the new Chairman of the Board of Directors. The leadership transition will become effective on January 1, 2024, as part of the management changes described below. "We founded Materialise with a mission to create a better and healt

      10/26/23 3:00:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology